Details of the Drug Formulations

General Information of Drug (ID: DM20LIM)

• Drug Name: Bremelanotide Drug Info
• Synonyms: Bremelanotide (USAN/INN); PT-141; Rekynda

Indication

Disease Entry	ICD 11	Status	REF
Hypoactive sexual desire dysfunction	HA00	Approved	[1]
Erectile dysfunction	HA01.1	Phase 3	[2]

• Cross-matching ID:
  PubChem CID: 9941379
  CAS Number: 189691-06-3
  TTD ID: D0X9PF
  ACDINA ID: D00888

Full List of Drug Formulations Containing This Drug

Bremelanotide 1.75 mg/0.3 ml Injection

Company	Formulation ID	FDA Description
Amag Pharmaceuticals	F23651	Glycerin; Sterile Water For Injection; Hydrochloric Acid; Sodium Hydroxide
Palatin Technologies	F23650	Glycerin; Sterile Water For Injection; Hydrochloric Acid Or Sodium Hydroxide

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
• [2] Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66.